| 6621 |
Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin |
Department of Pharmacology |
2015 |
| 6622 |
Vitamin D status and viral response to therapy in hepatitis C infected children |
Department of Pediatrics |
2015 |
| 6623 |
Vitamin D status and viral response to therapy in hepatitis C infected children |
Department of Clinical Pathology |
2015 |
| 6624 |
Vitamin D status and viral response to therapy in hepatitis C infected children |
Department of Clinical Pathology |
2015 |
| 6625 |
Vitamin D status and viral response to therapy in hepatitis C infected children |
Department of Diagnostic Radiology |
2015 |
| 6626 |
Vitamin D status and viral response to therapy in hepatitis C infected children" |
Department of Diagnostic Radiology |
2015 |
| 6627 |
Vitamin D status and viral response to therapy in hepatitis C infected children" |
Department of Pediatrics |
2015 |
| 6628 |
Vitamin D status and viral response to therapy in hepatitis C infected children" |
Department of Clinical Pathology |
2015 |
| 6629 |
Vitamin D status and viral response to therapy in hepatitis C infected children" |
Department of Clinical Pathology |
2015 |
| 6630 |
Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children |
Department of Neurology and Psychiatry |
2015 |